What's Happening?
Altura has announced an expansion of its contract with The Michael J. Fox Foundation for Parkinson's Research to increase access to Parkinson's and brain health studies in primary care and community health settings. This initiative aims to involve historically
underrepresented communities in research. Altura will collaborate with primary care organizations (PCOs) across various regions to promote participation in two key studies: the Parkinson's Progression Markers Initiative (PPMI) and the Black & African American Connections to Parkinson's Disease (BLAAC PD) study. These studies are designed to gather data on Parkinson's disease progression and genetic factors, respectively. The initiative will involve several PCOs, including those in Chicago, Houston, Phoenix, San Francisco, Shreveport, and St. Louis.
Why It's Important?
This initiative is significant as it seeks to address the underrepresentation of certain communities in medical research, which can lead to more inclusive and comprehensive findings. By integrating Parkinson's research into primary care settings, the project aims to make participation more accessible and convenient for patients, potentially leading to breakthroughs in understanding and treating Parkinson's disease. The involvement of diverse populations is crucial for developing treatments that are effective across different demographic groups, ultimately contributing to more equitable healthcare outcomes.
What's Next?
The project will continue to identify and support additional PCOs to expand the reach of these studies. As the initiative progresses, it is expected to gather valuable data that could inform future research and treatment strategies for Parkinson's disease. The success of this project could serve as a model for similar initiatives in other areas of medical research, promoting broader participation and inclusivity.
